IS SHIRISHADI GHRUTA IS EFFECTIVE IN MANAGEMENT OF STRACH MARKS DURING PREGNANCY
Phase 1
Not yet recruiting
- Conditions
- Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium
- Registration Number
- CTRI/2023/11/059749
- Lead Sponsor
- SANE GURUJI AROGYA KENDRA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
PRIMI GRAVIDA OF 20 TO 40 YEARS OF AGE.
FROM 20TH WEEK OF PREGNANCY UPTO DELIVERY
Exclusion Criteria
MULTIPARA.
SKIN DISEASE.
POLY HYDROMNIOS
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TO STUDY THE EFFECT OF SHIRISHADI GHRUTA IN GARBHINI KIKKISA CLINICALLYTimepoint: PRIMI GRAVIDA PATIENT WITH AGE BETWEEN 20-40 YEARS <br/ ><br>PATIENT WITH GESTATION AGE 20 WEEK TO FULL TERM
- Secondary Outcome Measures
Name Time Method ITERATURE STUDY OF KIKKISA AND STRAIE GRAVIDRUMTimepoint: STUDY WILL BE DONE USING AYURVEDIC GRANTHAS AND MODERN TEXT 20 WEEK TILL DELIVERY;TO OBSERVE ADVERSE EFFECT IF ANY IN 20 WEEK OF PREGNANCY TILL DELIVERYTimepoint: DURING TREATMENT OBSERVATION WILL BE DONE FOR ANY ADVERSE EFFECT ON PATIENTS
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Shirishadi Ghrita's efficacy in reducing striae gravidarum during pregnancy?
How does Shirishadi Ghrita compare to standard-of-care treatments for striae gravidarum in terms of effectiveness and safety?
Are there specific biomarkers that predict response to Shirishadi Ghrita in managing striae gravidarum in pregnant women?
What are the potential adverse events associated with Shirishadi Ghrita use during pregnancy and how are they managed?
What related compounds or combination therapies are being explored for striae gravidarum alongside Shirishadi Ghrita in clinical research?